The world of sleep supplements is a fascinating one, and a recent study has shed light on a novel approach to improving sleep quality. In a groundbreaking development, a hydrolyzed chicken extract called ProBeptigen has shown promise in enhancing perceived sleep quality among middle-aged adults with poor baseline sleep. This is particularly intriguing given the high prevalence of sleep difficulties across Asia, as highlighted by population surveys.
The study, funded by Suntory Beverage & Food Asia, conducted a randomized, double-blind, placebo-controlled trial with 52 healthy subjects aged 35 to 65 years old. Participants were randomly assigned to receive either 670mg of ProBeptigen or a placebo daily for four weeks. While changes in PSQI global scores did not significantly differ between the two groups, the improvement in the subjective sleep quality component score was significantly greater in the ProBeptigen group (p = 0.006).
This finding is not isolated. Previous studies have explored the effects of protein hydrolysates on sleep. In a trial with Japanese participants suffering from insomnia, bovine alpha-S1 casein tryptic hydrolysate significantly improved PSQI global scores and subjective sleep quality component scores after two weeks, and sleep latency and daytime function after four weeks. Similarly, a four-week study in Korean participants and a four-week study in a healthy German population also demonstrated improvements in PSQI global scores and various sleep-related components.
What makes ProBeptigen stand out is its potential to offer a stronger improvement in perceived sleep quality. The study found a larger, statistically significant between-group difference (-0.438 points) compared to other studies, suggesting that specific bioactive constituents in hydrolyzed chicken extract may contribute to this effect. The authors highlight the presence of various diketopiperazines and tryptophan in ProBeptigen, which may influence neurotransmitter systems and exhibit sedative effects.
However, the exact mechanisms by which ProBeptigen affects sleep quality remain unclear. The study did not directly assess the mechanistic pathways, and further research is needed to clarify these hypotheses. This includes evaluating alternative dosing schedules, larger sample sizes, and incorporating objective sleep measures. Despite this, the findings suggest that ProBeptigen could be a valuable addition to a multifaceted sleep management strategy.
In conclusion, this study highlights the potential of hydrolyzed chicken extract as a novel approach to improving sleep quality. While more research is needed to fully understand its mechanisms, the findings are encouraging and warrant further exploration. As we delve into the world of nutritional supplements, ProBeptigen offers a fascinating glimpse into the potential of natural ingredients to enhance our sleep health.
